drugset / Trial / NCT01621321

Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis

NCT01621321

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a research project to evaluate the efficacy and safety of two different treatment protocols in Allergic bronchopulmonary Aspergillosis.

Timeline

Start
2013-06
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 0.125 mg/kg
Subject Voriconazole Small molecule 200 mg